Cubist Systematic Strategies’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-334,632
| Closed | -$4.81M | – | 2294 |
|
|
2024
Q4 | $4.81M | Buy |
334,632
+110,682
| +49% | +$1.59M | 0.03% | 363 |
|
|
2024
Q3 | $5.06M | Buy |
+223,950
| New | +$5.06M | 0.03% | 354 |
|
|
2024
Q2 | – | Sell |
-365,322
| Closed | -$13.7M | – | 2600 |
|
|
2024
Q1 | $13.7M | Buy |
365,322
+241,958
| +196% | +$9.08M | 0.08% | 160 |
|
|
2023
Q4 | $6.9M | Buy |
123,364
+59,866
| +94% | +$3.35M | 0.04% | 352 |
|
|
2023
Q3 | $2.62M | Sell |
63,498
-105,351
| -62% | -$4.35M | 0.02% | 688 |
|
|
2023
Q2 | $9.43M | Buy |
+168,849
| New | +$9.43M | 0.06% | 281 |
|
|
2023
Q1 | – | Sell |
-175,048
| Closed | -$6.38M | – | 3282 |
|
|
2022
Q4 | $6.38M | Sell |
175,048
-55,399
| -24% | -$2.02M | 0.04% | 534 |
|
|
2022
Q3 | $6.56M | Buy |
230,447
+52,941
| +30% | +$1.51M | 0.04% | 611 |
|
|
2022
Q2 | $8.03M | Buy |
177,506
+48,890
| +38% | +$2.21M | 0.05% | 487 |
|
|
2022
Q1 | $9.78M | Buy |
128,616
+126,018
| +4,851% | +$9.59M | 0.08% | 309 |
|
|
2021
Q4 | $387K | Sell |
2,598
-2,968
| -53% | -$442K | ﹤0.01% | 2629 |
|
|
2021
Q3 | $810K | Sell |
5,566
-10,114
| -65% | -$1.47M | 0.01% | 1687 |
|
|
2021
Q2 | $3.07M | Buy |
15,680
+15,607
| +21,379% | +$3.06M | 0.03% | 817 |
|
|
2021
Q1 | $13K | Sell |
73
-24,228
| -100% | -$4.31M | ﹤0.01% | 2780 |
|
|
2020
Q4 | $3.44M | Sell |
24,301
-14,102
| -37% | -$2M | 0.05% | 637 |
|
|
2020
Q3 | $4.79M | Buy |
38,403
+28,637
| +293% | +$3.57M | 0.07% | 431 |
|
|
2020
Q2 | $872K | Buy |
9,766
+9,685
| +11,957% | +$865K | 0.02% | 1263 |
|
|
2020
Q1 | $5K | Sell |
81
-3,183
| -98% | -$196K | ﹤0.01% | 2098 |
|
|
2019
Q4 | $249K | Buy |
3,264
+2,087
| +177% | +$159K | ﹤0.01% | 1941 |
|
|
2019
Q3 | $59K | Buy |
+1,177
| New | +$59K | ﹤0.01% | 2018 |
|